ASENT: American Society for Experimental NeuroTherapeutics

Schedule

Presenters and presentation times are subject to change.

Thursday, March 11, 2004
9:30 am – 6:30 pm	Registration Ballroom Foyer
8:00 am – 10:00 am	ASENT Board of Directors Meeting Baccarat Suite
10:00 am – 1:00 pm	ASENT Advocacy Forum Neurotherapeutics Development – A Roadmap for Advocacy Groups Waterford/Lalique Suites Speakers: Christopher Gallen, MD PhD, Rullell Katz, MD, David Roth, MD This presentation will give an overview of neurotherapeutics development encompassing the academic, industrial and regulatory perspectives.The purpose of this presentation is to educate potential advocates as to how the development process works, where the potential influence points are, and the hurdles of bringing a drug to market. **Please note, attendance at the Advocacy Forum is included with your 6th Annual Meeting registration, however, individuals who want to attend ONLY the Advocacy Forum may do so at no charge. Either way, please complete the ASENT Advocacy Forum Registration Form and fax it to the ASENT Executive Office at (414) 276-3349.
1:00 pm – 5:00 pm	Mini-Course: "Clinical Trials: From Discovery to Approval"* Haverford/Baccarat Suites Chair: Karl Kieburtz, MD
1:00 pm – 1:15 pm	Overview and Content Karl Kieburtz, MD
1:15 pm – 2:00 pm	Clinical Equipoise and the Consent Process Ira Shoulson, MD
2:00 pm – 2:45 pm	Phase 2: A Critical Juncture in Therapeutic Development Marc Walton, MD PhD
2:45 pm – 3:15 pm	Coffee Break Ballroom Foyer
3:15 pm – 4:00 pm	Advancing a Research Protocol in Industry Christopher Gallen, MD PhD
4:00 pm – 4:45 pm	New Investigator View Thomas Guttuso, MD
2:00 pm – 5:00 pm	Poster Set-up Chesapeake Suites
5:00 pm – 8:00 pm	Information Exchange and Poster Presentation Reception Chesapeake Suites

Friday, March 12, 2004
7:00 am – 5:00 pm	Registration Ballroom Foyer
7:00 am – 5:00 pm	Speaker Ready Room Tiffany Salon
7:30 am – 8:30 am	Continental Breakfast Ballroom Foyer
8:00 am – 8:05 am	Welcome and Introductory Remarks Kathleen Clarence-Smith, MD PhD ASENT President Crystal Ballroom
8:05 am – 12:30 pm	Symposium: "Placebos and Active Controls in Clinical Trials" Crystal Ballroom Co-Chair: Mark Corrigan, MD Co-Chair: Karl Kieburtz, MD
8:05 am – 10:00 am	Regulatory Perspectives in the Use of Placebos and Active Controls Robert Temple, MD Statistical Facets of Equivalence Trials Richard Chappell, PhD Industry Perspective on the use of Placebos and Active Controls Mark Corrigan, MD
10:00 am – 10:30 am	Coffee Break Ballroom Foyer
10:30 am – 12:30 pm	Use of Gingko Biloba in Dementia and Alzheimer’s Disease: The Gingko in Evaluation of Memory (GEM) Dementia Prevention Trial Steven DeKosky, MD Doubling Your Pleasure: The Placebo Effect in Neurological Illness A. Jon Stoessl, MD A Participant’s Perspective On Placebos Jeffrey Martin, Esq.
12:30 pm – 1:00 pm	ASENT Annual Business Meeting Crystal Ballroom
12:30 pm – 2:00 pm	Lunch Break
1:00 pm – 2:00 pm	Editorial Board Meeting Room TBD
2:00 pm – 5:30 pm	Workshop #1: “The Genomics Era: Implications for Research and Health Care” Haverford Suite Co-Chair: Patricia Grady, PhD Co-Chair: Robert W. Hamill, MD
2:00 pm – 2:45 pm	After the Human Genome Project: What’s Next? Alan Guttmacher, MD
2:45 pm – 3:30 pm	Policy Challenges of New Genetic Technologies Kathy Hudson, PhD
3:30 pm – 4:00 pm	Coffee Break Ballroom Foyer
4:00 pm – 4:45 pm	“Privacy” in Research Ellen Wright Clayton, MD JD
4:45 pm – 5:30 pm	Panel Discussion and Questions
2:00 pm – 5:30 pm	Workshop #2: “Neuroimaging as an Outcome Measure” Lalique Suite Co-Chair: Rohit Bakshi, MD Co-Chair: Marc Walton, MD PhD
2:00 pm – 2:15 pm	Evolution of Neuroimaging Technology Rohit Bakshi, MD
2:15 pm – 2:30 pm	Range of Purposes of Imaging in Clinical Trials Marc Walton, MD PhD
2:30 pm – 3:20 pm	Neuroimaging in Alzheimer’s Disease Studies Russell Katz, MD
3:20 pm – 3:50 pm	Coffee Break Ballroom Foyer
3:50 pm – 4:40 pm	Neuroimaging in Multiple Sclerosis Studies Henry McFarland, MD
4:40 pm – 5:30 pm	Neuroimaging in Stroke Studies Steven Warach, MD
2:00 pm – 5:30 pm	Workshop #3: “Update on Clinical Trials" Baccarat Suite Co-Chair: Mark Corrigan, MD Co-Chair: Christopher Gallen, MD PhD
2:00 pm – 2:45 pm	Epilepsy Clinical Trials Jacqueline French, MD
2:45 pm – 3:30 pm	What’s New in Alzheimer’s Disease Clinical Trials Reisa Sperling, MD
3:30 pm – 4:00 pm	Coffee Break Ballroom Foyer
4:00 pm – 4:45 pm	Maligant Glioma Clinical Trials Mark Brown, MD
4:45 pm – 5:30 pm	Panel Discussion and Questions

Saturday, March 13, 2004
7:00 am – 3:00 pm	Registration Ballroom Foyer
7:00 am – 3:00 pm	Speaker Ready Room Tiffany Salon
7:30 am – 9:00 am	Continental Breakfast Ballroom Foyer
8:30 am – 8:40 am	Opening remarks by Story Landis, PhD, Director of the National Institute of Neurological Disorders and Stroke
8:40 am – 12:00 pm	Symposium: "Translational Neurotherapeutics" Crystal Ballroom Co-Chair: Christopher Gallen, MD PhD Co-Chair: Robert W. Hamill, MD
8:40 am – 9:15 am	Keynote Address: Translational Neuroscience: From Molecules to Humans Floyd Bloom, MD
9:15 am - 9:45 am	Functions of the Proteasome: From Cell Biology to Cancer Therapy Alfred Goldberg, MD
9:45 am - 10:15 am	Pathogenic Mechanisms as Therapeutic Targets in Parkinson’s Disease J. Timothy Greemamyre, MD PhD
10:15 am – 10:40 am	Coffee Break Ballroom Foyer
10:40 am – 11:05 am	Beta Amyloid Peptide as an Immunotherapy for Treatment of Alzheimer’s Disease Dale Schenk, MD
11:05 am - 11:30 am	Regulatory Perspective of Biomarkers in Translational Research Russell Katz, MD
11:30 am – 12:00 pm	Panel Discussion and Questions
12:00 pm - 2:00 pm	ASENT Program Committee Meeting Executive Boardroom
1:00 pm - 5:00 pm	Satellite Symposium: “Genetic Testing for Parkinson’s Disease and Related Disorders” Presented by the National Institute of Neurological Disorders and Stroke Old Georgetown Room
* Please note: Workshop participation is included in the registration fee, but you must register in advance by checking the appropriate box on the registration form. Workshop registration is on a first come, first served basis.